Press release
Sarcopenia Market to reach USD 4.01 Bn by 2029, emerging at a CAGR of 5.6 percent and forecast 2023-2029
Sarcopenia Market
The Sarcopenia Market report provides an extensive overview of the global market, including growth factors, limitations, and emerging industry trends. The report segments the Sarcopenia market by treatment type, route of administration, distribution channel, end-user market, and region. The research methodology involves primary research through interviews with industry experts, clinicians, and patients, complemented by secondary research utilizing data from publications, government websites, and other reliable sources. Statistical tools, such as descriptive statistics and forecasting models, were employed for data analysis. Additionally, the report highlights key players in the market, offering insights into their business overview, financial status, and recent developments.
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/196035
Sarcopenia Market Dynamics:
With the global population aging, Sarcopenia has become a prevalent medical condition. By 2030, approximately 1 in 6 people worldwide will be 60 years or older. The rising awareness of Sarcopenia among both medical professionals and the general public is a significant driver of market growth. Increased awareness has led to early diagnosis and treatment, ultimately improving the quality of life and slowing the progression of the disease.
The high cost of treatment poses a significant challenge, especially for patients with limited financial means. Protein supplements and resistance training, common therapies for Sarcopenia, can be expensive and unaffordable for many individuals. Currently, there are no approved muscle-building agents available, leading to the limited availability of curative therapy. Additionally, regulatory hurdles in drug development and approval, along with the complexity of diagnosing Sarcopenia, further impede market growth.
Sarcopenia Market Regional Insights:
• North America: Dominates the market in 2022 and is expected to continue its dominance, thanks to a high occurrence of Sarcopenia among the elderly population, increased healthcare spending, and the presence of key market players.
• Asia-Pacific: Anticipates rapid growth due to a rising elderly population, increased healthcare expenditure, and the presence of pharmaceutical companies catering to market demands.
• Europe, the Middle East, and South America: Expected to experience substantial growth with fast Compound Annual Growth Rates (CAGRs), primarily driven by aging populations in these regions.
Request For Free Inquiry Report:https://www.maximizemarketresearch.com/inquiry-before-buying/196035
Sarcopenia Market Segmentation:
by Treatment Type
Protein Supplement
Vitamin B12 Supplement
Vitamin D & Calcium Supplement
Exercise therapy
Pharmacotherapy
Others
by Route of Administration
Oral
Parenteral
Enteral
by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
by End-User
Hospitals
Clinics
Homecare settings
Sarcopenia Market Key Players:
1. Bayer AG
2. Zydus Cadila
3. GlaxoSmithKline plc
4. Nestle Health Science
5. Sanofi S.A.
6. GlaxoSmithKline plc.
7. Novartis AG
8. Pfizer Inc.
9. AstaReal AB
10. Merck Sharp & Dohme Corp.
11. AbbVie Inc.
12. Abbott laboratories, Inc.
13. American Way (Amway) Corporation
14. F-Hoffmann La-Roche
15. Amgen Inc.
16. Johnson & Johnson
Get to Know More About This Market Study:https://www.maximizemarketresearch.com/market-report/sarcopenia-market/196035/
Table of content for the Sarcopenia Market includes:
1. Global Sarcopenia Market: Research Methodology
2. Global Sarcopenia Market: Executive Summary
• Market Overview and Definitions
• Introduction to the Global Market
• Summary
• Key Findings
• Recommendations for Investors
• Recommendations for Market Leaders
• Recommendations for New Market Entry
3.Global Sarcopenia Market: Competitive Analysis
• MMR Competition Matrix
• Market Structure by region
• Competitive Benchmarking of Key Players
• Consolidation in the Market
• M&A by region
• Key Developments by Companies
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Market Dynamics
• PORTERS Five Forces Analysis
• PESTLE
• Regulatory Landscape by region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
• COVID-19 Impact
4 . Company Profile: Key players
• Company Overview
• Financial Overview
• Global Presence
• Capacity Portfolio
• Business Strategy
• Recent Developments
Key Offerings:
• Past Market Size and Competitive Landscape (2022 to 2029)
• Past Pricing and price curve by region (2022 to 2029)
• Market Size, Share, Size and Forecast by different segment | 2022-2029
• Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
• Market Segmentation - A detailed analysis by growth and trend
• Competitive Landscape - Profiles of selected key players by region from a strategic perspective
• Competitive landscape - Market Leaders, Market Followers, Regional player
• Competitive benchmarking of key players by region
• PESTLE Analysis
• PORTER's analysis
• Value chain and supply chain analysis
• Legal Aspects of business by region
• Lucrative business opportunities with SWOT analysis
• Recommendations
More Related Reports:
Global Assisted Reproductive Technology Market : https://www.maximizemarketresearch.com/market-report/global-assisted-reproductive-technology-market/106520/
Smart Farming Market : https://www.maximizemarketresearch.com/market-report/global-smart-farming-market/22769/
Global Gastrointestinal Therapeutics Market : https://www.maximizemarketresearch.com/market-report/global-gastrointestinal-therapeutics-market/38877/
Global Microbial Fermentation Technology Market : https://www.maximizemarketresearch.com/market-report/global-microbial-fermentation-technology-market/3779/
Drill Bits Market for Oil and Gas Industry : https://www.maximizemarketresearch.com/market-report/drill-bits-market/11599/
Data Compression Software Market : https://www.maximizemarketresearch.com/market-report/global-data-compression-software-market/81561/
Global Blood Collection Tubes Market : https://www.maximizemarketresearch.com/market-report/global-blood-collection-tubes-market/54576/
Global Burn Ointment Market : https://www.maximizemarketresearch.com/market-report/global-burn-ointment-market/107774/
Global Passenger Service System Market : https://www.maximizemarketresearch.com/market-report/global-passenger-service-system-market/55624/
Global Mobile BI Market : https://www.maximizemarketresearch.com/market-report/global-mobile-bi-market/25512/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 mailto:sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcopenia Market to reach USD 4.01 Bn by 2029, emerging at a CAGR of 5.6 percent and forecast 2023-2029 here
News-ID: 3222145 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Power Semiconductor Market to Reach USD 51.83 Billion by 2030 at 3.18% CAGR - Po …
According to a new report by Maximize Market Research, the global power semiconductor market was valued at USD 41.63 billion in 2023 and is projected to reach USD 51.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.18% over the forecast period 2024-2030.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/28191/
♦ Key Highlights
Market Size & CAGR: USD 41.63 Bn in 2023, expected to reach USD 51.83 Bn by…
Microneedle Drug Delivery Systems Market Set to Reach US $ 9.46 Billion by 2030 …
According to a new report by Maximize Market Research, the global microneedle drug delivery systems market was valued at roughly US $ 6.11 billion in 2024 and is projected to reach approximately US $ 9.46 billion by 2030, growing at a compound annual growth rate (CAGR) of around 7.7%.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/215694/
♦ Key Highlights
Market size & CAGR: Estimated at ~US $ 6.11 billion in 2024, forecast to…
Automotive Paints Market Forecast to Reach USD 15.77 Billion by 2030 at 4.7 % CA …
According to a new report by Maximize Market Research, the global automotive paints market was valued at USD 10.85 billion in 2023 and is projected to reach USD 15.77 billion by 2030, growing at a CAGR of approximately 4.7 % during 2024-2030. The forecast covers global coatings used in vehicle manufacturing and refinish applications, with a focus on key regions such as Asia-Pacific, North America and Europe.
► Get a sample…
Petrochemicals Market Set to Reach USD 1,122.31 Billion by 2032 at a CAGR of 6.5 …
According to a new report by Maximize Market Research, the global petrochemicals market was valued at USD 678.13 billion in 2024 and is projected to reach USD 1,122.31 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032. The growth is anchored in expanding demand across automotive, electronics, construction, and packaging industries.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/126575/
♦ Key Highlights
Market size + CAGR:…
More Releases for Sarcopenia
Sarcopenia Market Size, Share & Growth Analysis 2034
Sarcopenia Market Overview
Sarcopenia is a condition characterized by the progressive loss of muscle mass, strength, and function, primarily affecting the elderly. This decline leads to increased frailty, higher risk of falls, and diminished quality of life. The rising global geriatric population has heightened the prevalence of sarcopenia, making it a significant public health concern. Consequently, there is a growing demand for effective treatments and interventions to manage and mitigate the…
Sarcopenia Treatment Market Future Prediction Report By 2030
Sarcopenia Treatment Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.…
Sarcopenia Treatment Market Report 2024 - Sarcopenia Treatment Market Size And G …
"The Business Research Company recently released a comprehensive report on the Global Sarcopenia Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The sarcopenia treatment market…
Sarcopenia Pipeline Insights Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Sarcopenia Pipeline constitutes 8+ key companies continuously working towards developing 10+ Sarcopenia Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Sarcopenia Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Sarcopenia NDA approvals (if any), and product…
Global Sarcopenia Therapeutic Market Research Report 2023
The global Sarcopenia Therapeutic market was valued at US$ 2867.6 million in 2022 and is anticipated to reach US$ 3484.4 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029.
view full report
https://reports.valuates.com/market-reports/QYRE-Auto-13K14453/global-sarcopenia-therapeutic
Sarcopenia Therapeutic Market
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the largest consumption region of…
Sarcopenia - Drug Pipeline Landscape, 2022
Sarcopenia is a condition characterized by the loss of muscle mass and strength. It can occur due to a variety of reasons, including aging, inactivity, and certain chronic diseases.
Aging is the most common cause of sarcopenia. As people age, they tend to become less active and lose muscle mass. This process is known as age-related muscle loss or sarcopenia with aging.
Inactivity can also lead to sarcopenia. People who are not…
